|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,340,000,000 |
Market
Cap: |
111.92(B) |
Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
52
Week Range: |
$69.43 - $90.4 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 125 |
Guru Rank Value : 7.5 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
31,549 |
36,546 |
56,412 |
75,447 |
Total Sell Value |
$2,684,057 |
$3,094,660 |
$4,783,517 |
$6,318,268 |
Total People Sold |
2 |
3 |
5 |
5 |
Total Sell Transactions |
2 |
3 |
8 |
10 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Anderson Richard H |
Director |
|
2019-04-30 |
4 |
D |
$88.81 |
$38,099 |
D/D |
(429) |
79,012 |
|
- |
|
Oleary Denise M |
Director |
|
2019-04-30 |
4 |
D |
$88.81 |
$38,099 |
D/D |
(429) |
64,236 |
|
- |
|
Craig Arnold |
Director |
|
2019-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,002 |
31,053 |
|
- |
|
Goldsmith Andrea Jo |
Director |
|
2019-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
259 |
259 |
|
- |
|
Nabel Elizabeth G |
Director |
|
2019-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,002 |
8,452 |
|
- |
|
Powell Kendall J |
Director |
|
2019-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,002 |
32,784 |
|
- |
|
Leavitt Michael O |
Director |
|
2019-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,002 |
18,311 |
|
- |
|
Lenehan James T |
Director |
|
2019-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,002 |
53,951 |
|
- |
|
Hogan Randall J |
Director |
|
2019-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,002 |
37,579 |
|
- |
|
Donnelly Scott C |
Director |
|
2019-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,002 |
11,359 |
|
- |
|
Anderson Richard H |
Director |
|
2019-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,002 |
79,441 |
|
- |
|
Oleary Denise M |
Director |
|
2019-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,002 |
64,665 |
|
- |
|
Oleary Denise M |
Director |
|
2019-04-01 |
4 |
OE |
$29.96 |
$80,023 |
D/D |
2,671 |
62,484 |
|
- |
|
Kuntz Richard |
SVP & Chief Medical & Science |
|
2019-03-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,778 |
103,241 |
|
- |
|
Lenehan James T |
Director |
|
2019-03-04 |
4 |
OE |
$29.96 |
$80,023 |
D/D |
2,671 |
51,808 |
|
- |
|
Ishrak Omar |
Chairman & CEO |
|
2019-01-09 |
4 |
B |
$84.05 |
$1,008,540 |
D/D |
12,000 |
570,722 |
2.81 |
- |
|
Parkhill Karen L |
EVP & Chief Financial Officer |
|
2019-01-09 |
4 |
B |
$83.87 |
$251,610 |
D/D |
3,000 |
83,680 |
2.74 |
- |
|
White Robert John |
EVP & President MITG |
|
2018-12-01 |
4 |
D |
$97.53 |
$165,606 |
D/D |
(1,698) |
47,590 |
|
- |
|
Liddicoat John R |
EVP & President of Americas |
|
2018-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,982 |
42,043 |
|
- |
|
Martha Geoffrey |
EVP & GroupPres Restora Therap |
|
2018-09-24 |
4 |
S |
$97.93 |
$4,876,667 |
D/D |
(49,799) |
59,202 |
|
- |
|
Martha Geoffrey |
EVP & GroupPres Restora Therap |
|
2018-09-24 |
4 |
OE |
$34.88 |
$1,820,026 |
D/D |
49,799 |
109,001 |
|
- |
|
Ishrak Omar |
Chairman & CEO |
|
2018-09-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,000 |
10,000 |
|
- |
|
Ishrak Omar |
Chairman & CEO |
|
2018-09-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
556,396 |
|
- |
|
Ishrak Omar |
Chairman & CEO |
|
2018-09-07 |
4 |
GA |
$0.00 |
$0 |
D/D |
4,580 |
566,396 |
|
- |
|
Ishrak Omar |
Chairman & CEO |
|
2018-09-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
4,580 |
7,615 |
|
- |
|
680 Records found
|
|
Page 15 of 28 |
|
|